文献速递急性肾损伤遗传性与小管间质肾病

肝损伤诱导的远程肾损伤与肝脏清除游离血红蛋白受损相关

Hepatic injury-induced remote kidney injury is associated with impaired hepatic clearance of cell-free hemoglobin.
PubMed 文献 · Nephrol Dial Transplant · 2026-08-25

本研究在小鼠肝缺血再灌注(HIR)模型中探讨远程肾损伤机制。HIR导致溶血、循环游离血红蛋白(CFH)和血红素升高,肝脏清除相关基因表达降低,肾近端小管细胞摄取血红蛋白并发生铁死亡。西司他丁或去铁胺可减轻肾损伤,提示CFH/血红素是HIR诱导远程肾损伤的介质。

要点

  • HIR后溶血及肝脏清除CFH/血红素受损导致循环CFH/血红素升高。
  • 肾脏近端小管细胞摄取血红蛋白,引发铁积累、脂质过氧化和铁死亡。
  • 西司他丁或去铁胺可保护肾脏,提示靶向溶血和CFH/血红素毒性是潜在策略。

核心结论

  • HIR诱导的远程肾损伤与肝脏清除CFH/血红素受损及溶血增加导致的循环CFH/血红素升高相关。
  • CFH/血红素是HIR诱导远程肾损伤的介质,靶向溶血和CFH/血红素细胞毒性可能治疗和预防远程器官损伤尤其是肾脏。

研究设计与样本

  • 小鼠肝缺血再灌注(HIR)模型,部分小鼠给予megalin阻断剂西司他丁或铁螯合剂/铁死亡抑制剂去铁胺。
  • 评估肝和肾损伤,分析溶血、肝脏CFH/血红素清除相关基因表达及肾脏铁死亡。

主要发现

  • HIR诱导肝和肾损伤,伴溶血、CFH/血红素水平升高及肝脏中触珠蛋白和血红素结合蛋白水平降低。
  • HIR导致血红蛋白内化进入近端小管细胞(PTCs)。
  • HIR增加肾脏血红素加氧酶-1表达、铁含量和脂质过氧化,降低谷胱甘肽水平,表明PTCs发生铁死亡。
  • 西司他丁阻止HIR诱导的肾脏血红蛋白摄取、铁积累和脂质过氧化,从而保护肾脏。
  • 去铁胺也保护肾脏对抗HIR。

临床怎么用

  • 对于肝缺血再灌注损伤患者,应关注远程肾损伤风险,监测溶血和CFH/血红素水平。
  • 靶向溶血和CFH/血红素细胞毒性(如西司他丁或去铁胺)可能成为治疗和预防远程肾损伤的策略。

局限性

  • 研究仅在小鼠模型中进行,结论需在人类中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND HYPOTHESIS: Hepatic ischemia-reperfusion (HIR) injury, often extends beyond the primary site and causes damage in distant organs, including the kidney. In particular, concomitant kidney injury occurring alongside with the liver injury represents a significant clinical problem, but this mechanistic understanding remains unclear. Given that the liver is the primary organ responsible for clearing cytotoxic cell-free hemoglobin (CFH) and heme released during hemolysis, we hypothesized that hemolysis and impaired hepatic clearance of these hemolysis-derived products following HIR may contribute to kidney injury. METHODS: Mice were subjected to HIR, after which liver and kidney injury were evaluated. Some mice were administered with cilastatin, a blocker of megalin, or deferoxamine, an iron chelator and ferroptosis inhibitor. After HIR, hemolysis, hepatic expression of CFH/heme clearance-related genes, and ferroptosis in the kidney were analyzed. RESULTS: HIR induced liver and kidney damage, accompanied by hemolysis, increased CFH/heme levels, and reduced levels of haptoglobin and hemopexin, key regulators of hepatic CFH/heme clearance, in the liver. HIR caused hemoglobin internalization into proximal tubule cells (PTCs). Furthermore, HIR increased heme oxygenase-1 expression, iron content, and lipid peroxidation in the kidneys, while decreasing glutathione levels, indicating that HIR induces ferroptosis in PTCs. Cilastatin prevented HIR-induced hemoglobin uptake, iron accumulation, and lipid peroxidation in the kidneys, thereby protecting the kidneys. Deferoxamine also protected the kidneys against HIR. CONCLUSION: These findings demonstrate that HIR-induced remote kidney injury (RKI) is associated with elevated circulating CFH/heme resulting from impaired hepatic CFH/heme clearance and increased hemolysis. This suggests that CFH/heme play as mediators of HIR-induced RKI, and that targeting hemolysis and CFH/heme cytotoxicity may be a strategy to treat and prevent remote organ injury, particularly in the kidneys.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Han YK, Lim HJ, Park YR, et al. Hepatic injury-induced remote kidney injury is associated with impaired hepatic clearance of cell-free hemoglobin. Nephrol Dial Transplant. 2026. PMID: 42640552. doi:10.1093/ndt/gfag190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。